Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Recent Jerini patent discloses novel agents for ocular disorders

Jan. 3, 2008

New site-directed nanoparticle delivery system useful to treat ocular inflammation in vivo

Jan. 3, 2008

ISTA submits NDA to FDA for Xibrom for inflammation, pain and photophobia

Dec. 27, 2007

Novel therapeutic agents for glaucoma reported in recent Allergan patents

Dec. 14, 2007

Silencing mTOR useful in experimental proliferative vitreoretinopathy

Dec. 11, 2007

InSite Vision files new drug submission with Health Canada for AzaSite for conjunctivitis

Dec. 5, 2007

FDA approves Alcon's Triesence for use in eye surgery

Dec. 3, 2007

Fovea and Genzyme Corporation enter research collaboration in ophthalmology

Nov. 29, 2007

Preclinical data show multiple mechanisms of action for sonepcizumab

Nov. 16, 2007

Lantibio and TRB Chemedica enter licensing agreement with Alcon for dry eye drug

Nov. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...